[Table 1](#pone.0151121.t001){ref-type="table"} appears incorrectly in the published article. Please see the correct [Table 1](#pone.0151121.t001){ref-type="table"} and its legend below.
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###### Tumor characteristics and engraftment rate.
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                                                Implanted (N)   Passaged (N, %)   P Value
  ----------------------- --------------------- --------------- ----------------- -----------------------------------------------
  Breast Cancer Subtype   TNBC                  13              7 (53.8%)         0.02[\*](#t001fn002){ref-type="table-fn"}
                          HER2+                 3               1 (33.3%)         ** **
                          HR+                   32              5 (15.6%)          
  NeoCT---Yes             TNBC                  9               5 (55.5%)         0.02[\*\*](#t001fn003){ref-type="table-fn"}
                          HER2+                 2               1 (50%)            
                          HR+                   13              5 (38.5%)          
  NeoCT---No              TNBC                  4               2 (50%)            
                          HER2+                 1               0 (0%)             
                          HR+                   19              0 (0%)             
  Response to NeoCT       Progressive Disease   7               6 (85.7%)         0.02[\*\*\*](#t001fn004){ref-type="table-fn"}
                          Stable Disease        9               2 (22.2%)          
                          Partial Response      8               3 (37.5%)          

NeoCT: Neoadjuvant chemotherapy

\*P value by Fisher exact analysis, comparing BCX engraftment in TNBC to HR+ breast cancer.

\*\*P value by Fisher exact analysis, comparing BCX engraftment in NeoCT to no NeoCT implantations.

\*\*\*P value by Fisher exact analysis, comparing BCX engraftment in tumors that progressed on NeoCT vs. those that had stable disease/partial response.
